These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 14604958)

  • 21. Ectopic retroviral expression of LMO2, but not IL2Rgamma, blocks human T-cell development from CD34+ cells: implications for leukemogenesis in gene therapy.
    Pike-Overzet K; de Ridder D; Weerkamp F; Baert MR; Verstegen MM; Brugman MH; Howe SJ; Reinders MJ; Thrasher AJ; Wagemaker G; van Dongen JJ; Staal FJ
    Leukemia; 2007 Apr; 21(4):754-63. PubMed ID: 17268520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells.
    Deleuze V; El-Hajj R; Chalhoub E; Dohet C; Pinet V; Couttet P; Mathieu D
    PLoS One; 2012; 7(7):e40484. PubMed ID: 22792348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosomal translocations and leukaemia: a role for LMO2 in T cell acute leukaemia, in transcription and in erythropoiesis.
    Rabbitts TH; Axelson H; Forster A; Grutz G; Lavenir I; Larson R; Osada H; Valge-Archer V; Wadman I; Warren A
    Leukemia; 1997 Apr; 11 Suppl 3():271-2. PubMed ID: 9209362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.
    Aplan PD; Jones CA; Chervinsky DS; Zhao X; Ellsworth M; Wu C; McGuire EA; Gross KW
    EMBO J; 1997 May; 16(9):2408-19. PubMed ID: 9171354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1.
    Gering M; Yamada Y; Rabbitts TH; Patient RK
    Development; 2003 Dec; 130(25):6187-99. PubMed ID: 14602685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TAL1 expression does not occur in the majority of T-ALL blasts.
    Delabesse E; Bernard M; Meyer V; Smit L; Pulford K; Cayuela JM; Ritz J; Bourquelot P; Strominger JL; Valensi F; Macintyre EA
    Br J Haematol; 1998 Jul; 102(2):449-57. PubMed ID: 9695959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice.
    Larson RC; Lavenir I; Larson TA; Baer R; Warren AJ; Wadman I; Nottage K; Rabbitts TH
    EMBO J; 1996 Mar; 15(5):1021-7. PubMed ID: 8605871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia.
    Aplan PD; Lombardi DP; Reaman GH; Sather HN; Hammond GD; Kirsch IR
    Blood; 1992 Mar; 79(5):1327-33. PubMed ID: 1311214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. V(D)J-mediated translocations in lymphoid neoplasms: a functional assessment of genomic instability by cryptic sites.
    Marculescu R; Le T; Simon P; Jaeger U; Nadel B
    J Exp Med; 2002 Jan; 195(1):85-98. PubMed ID: 11781368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequent clonal loss of heterozygosity (LOH) in the chromosomal region 1p32 occurs in childhood T cell acute lymphoblastic leukemia (T-ALL) carrying rearrangements of the TAL1 gene.
    Iolascon A; Faienza MF; Coppola B; Moretti A; Basso G; Amaru R; Viganò G; Biondi A
    Leukemia; 1997 Mar; 11(3):359-63. PubMed ID: 9067574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcription factors of the bHLH and LIM families: synergistic mediators of T cell acute leukemia?
    Baer R; Hwang LY; Bash RO
    Curr Top Microbiol Immunol; 1997; 220():55-65. PubMed ID: 9103675
    [No Abstract]   [Full Text] [Related]  

  • 32. Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T-cell leukemias.
    Bernard O; Guglielmi P; Jonveaux P; Cherif D; Gisselbrecht S; Mauchauffe M; Berger R; Larsen CJ; Mathieu-Mahul D
    Genes Chromosomes Cancer; 1990 Jan; 1(3):194-208. PubMed ID: 1964581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positive and negative transcriptional control by the TAL1 helix-loop-helix protein.
    Hsu HL; Wadman I; Tsan JT; Baer R
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5947-51. PubMed ID: 8016094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for leukemia- and clone-specific markers at birth in children with T-cell precursor ALL suggests a predominantly postnatal origin.
    Fischer S; Mann G; Konrad M; Metzler M; Ebetsberger G; Jones N; Nadel B; Bodamer O; Haas OA; Schmitt K; Panzer-Grümayer ER
    Blood; 2007 Oct; 110(8):3036-8. PubMed ID: 17557895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FOXP3 can modulate TAL1 transcriptional activity through interaction with LMO2.
    Fleskens V; Mokry M; van der Leun AM; Huppelschoten S; Pals CE; Peeters J; Coenen S; Cardoso BA; Barata JT; van Loosdregt J; Coffer PJ
    Oncogene; 2016 Aug; 35(31):4141-8. PubMed ID: 26686090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-related phenotypic and oncogenic differences in T-cell acute lymphoblastic leukemias may reflect thymic atrophy.
    Asnafi V; Beldjord K; Libura M; Villarese P; Millien C; Ballerini P; Kuhlein E; Lafage-Pochitaloff M; Delabesse E; Bernard O; Macintyre E
    Blood; 2004 Dec; 104(13):4173-80. PubMed ID: 15054041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoallelic or biallelic LMO2 expression in relation to the LMO2 rearrangement status in pediatric T-cell acute lymphoblastic leukemia.
    Van Vlierberghe P; Beverloo HB; Buijs-Gladdines J; van Wering ER; Horstmann M; Pieters R; Meijerink JP
    Leukemia; 2008 Jul; 22(7):1434-7. PubMed ID: 18079736
    [No Abstract]   [Full Text] [Related]  

  • 38. LIM domain only-2 (LMO2) induces T-cell leukemia by two distinct pathways.
    Smith S; Tripathi R; Goodings C; Cleveland S; Mathias E; Hardaway JA; Elliott N; Yi Y; Chen X; Downing J; Mullighan C; Swing DA; Tessarollo L; Li L; Love P; Jenkins NA; Copeland NG; Thompson MA; Du Y; Davé UP
    PLoS One; 2014; 9(1):e85883. PubMed ID: 24465765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of SIL-TAL1 fusion gene transcripts associated with human T-cell lymphocytic leukemia by real-time reverse transcriptase-PCR.
    Curry JD; Smith MT
    Leuk Res; 2003 Jul; 27(7):575-82. PubMed ID: 12681356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
    Gerby B; Tremblay CS; Tremblay M; Rojas-Sutterlin S; Herblot S; Hébert J; Sauvageau G; Lemieux S; Lécuyer E; Veiga DF; Hoang T
    PLoS Genet; 2014 Dec; 10(12):e1004768. PubMed ID: 25522233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.